Chris Miller, PhD

Chris Miller, PhD, is the Director of Regulatory Affairs Clinical and Nonclinical Strategy at Pacira BioSciences. He completed his PhD in Epidemiology at the University of Pennsylvania under the mentorship of Dr. John Farrar, with dissertation research supported by the FDA focusing on the design and analysis of acute pain clinical trials. His doctoral work addressed methodological challenges in pain research, including establishing minimum clinically important differences in pain intensity, developing a more patient-centered efficacy endpoint for multi-dose clinical trials, and creating a reference-based multiple imputation approach to minimize bias introduced by rescue pain medication. Prior to his doctoral training, Chris served as Scientific Executive Consultant at 3D Communications for over ten years, where he led preparations for more than 30 FDA Advisory Committee meetings, with particular expertise in pain therapeutics. He has also served as a Biostatistics Subject Matter Expert for the Gates Foundation. Chris earned his MS in Biostatistics from the University of Minnesota. In his role at Pacira, Chris applies his methodological expertise to the development of non-opioid pain therapeutics, providing strategic guidance on clinical trial design and regulatory submissions.